Comparison of pro‐inflammatory cytokines of non‐healing and healing cutaneous leishmaniasis

Cutaneous leishmaniasis (CL) heals spontaneously within several weeks or months, but, in rare cases, CL‐active lesions last for many years. In this study, we assessed cell‐mediated immunity in non‐healing CL through the measurement of three pro‐inflammatory cytokines: Interferon‐γ (IFN‐γ), IL‐17a an...

Full description

Saved in:
Bibliographic Details
Published inScandinavian journal of immunology Vol. 85; no. 4; pp. 291 - 299
Main Authors Moafi, M., Rezvan, H., Sherkat, R., Taleban, R., Asilian, A., Hamid Zarkesh‐Esfahani, S., Nilforoushzadeh, M. A., Jaffary, F., Mansourian, M., Sokhanvari, F., Ansari, N.
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.04.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cutaneous leishmaniasis (CL) heals spontaneously within several weeks or months, but, in rare cases, CL‐active lesions last for many years. In this study, we assessed cell‐mediated immunity in non‐healing CL through the measurement of three pro‐inflammatory cytokines: Interferon‐γ (IFN‐γ), IL‐17a and CXCL‐11. For this, 32 patients afflicted with healing or non‐healing CL were recruited in this study. Peripheral blood mononuclear cells (PBMCs) of every patient were treated with three antigens: purified protein derivative (PPD), soluble Leishmania antigen (SLA) and phytohaemagglutinin (PHA). Cytokine quantification was performed using enzyme‐linked immunosorbent assay (ELISA) method. Results of our study showed that neither cytokine produced in the presence of a PPD stimulator (as an irrelevant antigen) significantly differed between the healing and non‐healing groups (P‐value ≥0.05 for all of them). However, IFN‐γ, CXCL‐11 and IL‐17a levels produced in the presence of PHA or SLA were significantly higher within the healing than in the non‐healing group (P‐value <0.01 for all of them). It seems that appropriate levels of IFN‐γ, as well as IL‐17a and CXCL‐11, contribute to the control of Leishmania infection.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0300-9475
1365-3083
DOI:10.1111/sji.12534